DxS appoints Ron Long non-executive director
This article was originally published in Clinica
Manchester, UK-based companion diagnostics specialist DxS has made Ron Long non-executive director. Mr Long has had 40 years of experience in the pharmaceutical industry. He was most recently CEO for Amersham Pharmacia Biotech and vice-chairman of Amersham before retiring in 2001. He also worked with the Wellcome Foundation for over 22 years. Mr Long holds a number of other board positions including Medivir and Procognia Israel.